These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9373000)

  • 1. Implementing quality assurance programs in multigroup practices for treating hypercholesterolemia in patients with coronary artery disease.
    Gerber J
    Am J Cardiol; 1997 Oct; 80(8B):57H-61H. PubMed ID: 9373000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists.
    Bramlet DA; King H; Young L; Witt JR; Stoukides CA; Kaul AF
    Am J Cardiol; 1997 Oct; 80(8B):39H-44H. PubMed ID: 9372997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid management in a private cardiology practice (the Midwest Heart experience).
    Brown AS; Cofer LA
    Am J Cardiol; 2000 Feb; 85(3A):18A-22A. PubMed ID: 10695703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease.
    Lee TH; Cleeman JI; Grundy SM; Gillett C; Pasternak RC; Seidman J; Sennett C
    JAMA; 2000 Jan; 283(1):94-8. PubMed ID: 10632286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. Introduction.
    Jacobson TA
    Am J Med; 2001 Apr; 110 Suppl 6A():1S-2S. PubMed ID: 11311190
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical performance improvement series. Classic CQI integrated with comprehensive disease management as a model for performance improvement.
    Joshi MS; Bernard DB
    Jt Comm J Qual Improv; 1999 Aug; 25(8):383-95. PubMed ID: 10434189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction.
    Simpson RJ; Sueta CA; Boccuzzi SJ; Lulla A; Biggs D; Londhe A; Smith SC
    Am J Cardiol; 1997 Oct; 80(8B):53H-56H. PubMed ID: 9372999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid management program: results of applying national guidelines in a private practice.
    Robbins JA; Dickinson WA; Bartel AG; Hartman CW
    South Med J; 1993 Mar; 86(3):289-92. PubMed ID: 8451666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving cholesterol target in a managed care organization (ACTION) trial.
    Straka RJ; Taheri R; Cooper SL; Smith JC
    Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.
    Cohen MV; Byrne MJ; Levine B; Gutowski T; Adelson R
    Circulation; 1991 Apr; 83(4):1294-304. PubMed ID: 2013147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization.
    Paez KA; Allen JK
    J Am Acad Nurse Pract; 2006 Sep; 18(9):436-44. PubMed ID: 16958775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving patient outcomes by pooling resources (the Texas Heart Care Partnership experience).
    Hillert B; Remonte S; Rodgers G; Yancy CW; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):43A-51A. PubMed ID: 10695707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.
    Shaffer J; Wexler LF
    Arch Intern Med; 1995 Nov; 155(21):2330-5. PubMed ID: 7487258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK.
    Kotseva K; Jennings CS; Turner EL; Mead A; Connolly S; Jones J; Bowker TJ; Wood DA;
    Heart; 2012 Jun; 98(11):865-71. PubMed ID: 22581735
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.